Z-013

Zopiclone-N-oxide solution

100 μg/mL (Methanol with 1% 1 M HCl), ampule of 1 mL, certified reference material, Cerilliant^®

• Formule empirique (notation de Hill): C₁₇H₁₇ClN₆O₄
• Numéro CAS: 43200-96-0
• Poids moléculaire : 404.81
• Numéro MDL: MFCD00871938
• Code UNSPSC : 41116107
• ID de substance PubChem : 329831596
• Nomenclature NACRES : NA.24

Propriétés

• Qualité: certified reference material
• Forme: liquid
• Caractéristiques: (Snap-N-Spike^®)
• Conditionnement: ampule of 1 mL
• Fabricant/nom de marque: Cerilliant^®
• Concentration: 100 μg/mL (Methanol with 1% 1 M HCl)
• Technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Application(s): clinical testing
• Format: single component solution
• Température de stockage: −20°C
• Chaîne SMILES: O=C1N(C2=CC=C(Cl)C=N2)C(OC(N3CC[N+]([O-])(C)CC3)=O)C4=C1N=CC=N4
• InChI: 1S/C17H17ClN6O4/c1-24(27)8-6-22(7-9-24)17(26)28-16-14-13(19-4-5-20-14)15(25)23(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3
• Clé InChI: IPTIKKTXLHVRKN-UHFFFAOYSA-N

Description

Description générale

Zopiclone N-oxide is a primary, active metabolite of zopiclone in urine as well as a major pharmaceutical impurity of zopiclone known as eszopiclone impurity A. The parent drug, zopiclone, is a non-benzodiazepine hypnotic sold under the trade names Imovane^®and ZImovane^®and is used in the treatment of insomnia.

Application

• Enantioselective analysis of zopiclone and its metabolites: A study developed a DLLME-CE method for the enantioselective analysis of zopiclone and its active metabolite, zopiclone-N-oxide, post fungal biotransformation, demonstrating the utility of zopiclone-N-oxide as a reference standard in pharmaceutical metabolite profiling (de Albuquerque et al., 2015).


• Pharmacokinetic studies: An analytical method using liquid chromatography/tandem mass spectrometry was employed for the enantioselective analysis of zopiclone and its metabolites in plasma, showcasing zopiclone-N-oxide′s critical role in bioanalytical studies related to insomnia and GABA receptor modulation (Tonon et al., 2011).

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Imovane is a registered trademark of Sanofi-Aventis

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Informations sur la sécurité

• Pictogrammes: GHS02,GHS06,GHS08
• Mention d'avertissement: Danger
• Mentions de danger: H225,H301 + H311 + H331,H370
• Conseils de prudence: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Classification des risques: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Organes cibles: Eyes,Central nervous system
• Code de la classe de stockage: 3 - Flammable liquids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): 49.5 °F - closed cup
• Point d'éclair (°C): 9.7 °C - closed cup